Na Lu - Publications

[18F]FAPI- 04 PET/CT for pathologic response assessment in pancreatic cancer patients with systemic treatment.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 28, 2025

Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer.

Journal: Nature communications

Published: November 26, 2024

Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.

Journal: The Journal of clinical investigation

Published: September 12, 2024

Siamese Delta Network with Multimodality Fusion for Systemic Treatment Response Prediction in Pancreatic Cancer.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 12, 2023

18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 21, 2023

Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers.

Journal: Cancer letters

Published: February 10, 2023

Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery.

Journal: BMC cancer

Published: July 15, 2022

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.

Journal: Liver cancer

Published: June 16, 2022